Show simple item record

Inanspruchnahme ambulanter ärztlicher Leistungen während der COVID-19-Pandemie bei Menschen mit Diabetes in Deutschland
[journal article]

dc.contributor.authorDu, Yongde
dc.contributor.authorBaumert, Jensde
dc.contributor.authorDamerow, Stefande
dc.contributor.authorRommel, Alexanderde
dc.contributor.authorScheidt-Nave, Christade
dc.contributor.authorHeidemann, Christinde
dc.date.accessioned2022-02-28T15:26:06Z
dc.date.available2022-02-28T15:26:06Z
dc.date.issued2021de
dc.identifier.issn2511-2708de
dc.identifier.urihttps://www.ssoar.info/ssoar/handle/document/77764
dc.description.abstractPeople with diabetes regularly need outpatient medical care due to their disease and possible concomitant and secondary illnesses. Using data from the nationwide GEDA 2019/2020-EHIS survey conducted from April 2019 to September 2020, the present study examines developments in outpatient utilisation behaviour during the measures put in place to contain the SARS-CoV-2 pandemic. During the observation period, people with diabetes had a significantly higher rate of utilisation of medical services provided by general practitioners (GPs) and specialists than the population as a whole. In the spring of 2020, when the restrictions were put in place, utilisation of specialist medical services by people with diabetes decreased temporarily by 46% compared to the 2019 reference period. In contrast, no relevant decline in the utilisation of medical services provided by GPs was observed, but this could be related to adaptations of care provision through telephone consultations for people with regularly requiring GP office visits. The issue examined here requires further observations in view of the renewed containment measures.de
dc.languageende
dc.subject.ddcSozialwissenschaften, Soziologiede
dc.subject.ddcSocial sciences, sociology, anthropologyen
dc.subject.othermedical services; diabetes; SARS-COV-2; COVID-19; GEDA 2019/2020-EHIS; 2018 microcensusde
dc.titleUtilisation of outpatient medical services by people with diagnosed diabetes during the COVID-19 pandemic in Germanyde
dc.title.alternativeInanspruchnahme ambulanter ärztlicher Leistungen während der COVID-19-Pandemie bei Menschen mit Diabetes in Deutschlandde
dc.description.reviewbegutachtet (peer reviewed)de
dc.description.reviewpeer revieweden
dc.source.journalJournal of Health Monitoring
dc.source.volume6de
dc.publisher.countryDEUde
dc.source.issue2de
dc.subject.classozGesundheitspolitikde
dc.subject.classozHealth Policyen
dc.subject.thesozInanspruchnahmede
dc.subject.thesozrecourseen
dc.subject.thesozGesundheitsleistungde
dc.subject.thesozhealth serviceen
dc.subject.thesozchronische Krankheitde
dc.subject.thesozchronic illnessen
dc.subject.thesozEpidemiede
dc.subject.thesozepidemicen
dc.subject.thesozambulante Behandlungde
dc.subject.thesozoutpatient treatmenten
dc.subject.thesozambulante Versorgungde
dc.subject.thesozoutpatient careen
dc.subject.thesozGesundheitsversorgungde
dc.subject.thesozhealth careen
dc.subject.thesozmedizinische Versorgungde
dc.subject.thesozmedical careen
dc.subject.thesozIndikatorde
dc.subject.thesozindicatoren
dc.subject.thesozBundesrepublik Deutschlandde
dc.subject.thesozFederal Republic of Germanyen
dc.identifier.urnurn:nbn:de:0168-ssoar-77764-5
dc.rights.licenceCreative Commons - Namensnennung 4.0de
dc.rights.licenceCreative Commons - Attribution 4.0en
ssoar.contributor.institutionFDBde
internal.statusformal und inhaltlich fertig erschlossende
internal.identifier.thesoz10047100
internal.identifier.thesoz10079581
internal.identifier.thesoz10040302
internal.identifier.thesoz10042424
internal.identifier.thesoz10035396
internal.identifier.thesoz10035400
internal.identifier.thesoz10045504
internal.identifier.thesoz10034647
internal.identifier.thesoz10047129
internal.identifier.thesoz10037571
dc.type.stockarticlede
dc.type.documentZeitschriftenartikelde
dc.type.documentjournal articleen
dc.source.pageinfo51-58de
internal.identifier.classoz11006
internal.identifier.journal1954
internal.identifier.document32
internal.identifier.ddc300
dc.source.issuetopicDiabetes surveillance in Germany: New results within the context of diabetes care and the COVID-19 pandemicde
dc.identifier.doihttps://doi.org/10.25646/8333de
dc.description.pubstatusVeröffentlichungsversionde
dc.description.pubstatusPublished Versionen
internal.identifier.licence16
internal.identifier.pubstatus1
internal.identifier.review1
dc.subject.classhort11000de
internal.pdf.wellformedtrue
internal.pdf.encryptedfalse


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record